Ubs Asset Management Americas Inc Axsome Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 134,101 shares of AXSM stock, worth $16.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
134,101
Previous 74,892
79.06%
Holding current value
$16.1 Million
Previous $8.73 Million
60.27%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding AXSM
# of Institutions
403Shares Held
37.3MCall Options Held
507KPut Options Held
540K-
Vanguard Group Inc Valley Forge, PA3.95MShares$473 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$396 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$203 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$182 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$136 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.14B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...